SGCB and Hepatic fibrosis: Kruppel-like factor 2 (KLF2), a transcription factor capable of positively regulating the eNOS-sGC pathway maintains LSECs differentiation, has been demonstrated to facilitate the inactivation of HSCs activation and apoptosis to alleviate liver fibrosis by Simvastatin (Marrone et al., 2015).